MTRC released a White Paper with a brief overview of the market access landscape for IVD tests in Europe

Market access for in-vitro diagnostic (IVD) testing is a challenging field. It includes co-existing frameworks of reimbursement (coding, payment mechanism tariffs), funding (post-reimbursement approval by payers), and health technology assessment (HTA). 

For most of the Med Tech companies, the starting point for understanding the European market is EU5 countries: England, France, Germany, Italy, and Spain.

Despite the single similarity of large populations, these countries are organized completely differently from the market access perspective.

MTRC developed an analytical White Paper with a summary of key market access elements of EU5 countries, including stakeholders, payment mechanisms, innovative payment schemes, funding, and the role of HTA for in-vitro diagnostic tests.

Read more and request a White Paper here.